Method of treating ulcerative colitis or crohn's disease by administering an antibody to&agr;E&bgr;7 integrin
US6455042B1 · kind B1 · utility
4Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1999 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Apr 16, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating an autoimmune disease, such ulcerative coliteis or crohns disease characterized by lymphocyte accumulation at epithelial sites. The method involves administering to a subject an effective amount of an antibody that selectively binds to an &agr;E&bgr;7 integrin or an &agr;E subunit thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.